朝藿定A
分析標(biāo)準(zhǔn)品,HPLC≥98%
Epimedin A
CAS號：110623-72-8
分子式：C39H50O20
分子量：838.81
MDL：MFCD30496681
別名：淫羊霍定A; 朝藿定A;;1-Methoxy-10H-9-thia-2,4-diaza-phenanthren-3-ylamine
貨號 | 規(guī)格/參數(shù)/品牌 | 價格 | 貨期 |
YJ-B20170-20mg | 分析標(biāo)準(zhǔn)品,HPLC≥98% | ￥1100.00 | 現(xiàn)貨 |
產(chǎn)品介紹
熔點：206-207℃
沸點：1099.831℃ at 760 mmHg
外觀：棕黃色結(jié)晶粉末
溶解性：Methanol : 62.5 mg/mL (74.51 mM; Need ultrasonic)
儲存條件：2-8℃
注意：部分產(chǎn)品我司僅能提供部分信息，我司不保證所提供信息的權(quán)威性，僅供客戶參考交流研究之用。
參考文獻(xiàn)(35篇)
35. [IF=3.8] Jialu Shen et al."Insights into inhibitory mechanisms: Unraveling the structure-activity relationship of dietary flavonoids on gut bacterial β-glucuronidase."Journal of Functional Foods.2024 Nov;122:106510
34. [IF=4.3] Yang Linlin et al."Spraying methyl jasmonate before harvesting can significantly increase the content of icariin in an important leaf medicinal herb, Epimedium sagittatum, by activating the expression of genes involved in flavonoid synthesis pathways."BMC
33. [IF=6.7] Xinguang Liu et al."Screening effective-component compatibility from Jinshui Chenfei formula for silicosis treatment by serum-pharmacochemistry and feedback system control."PHYTOMEDICINE.2025 Mar;138:156419
32. [IF=4.4] Chen Yangfeng et al."In Vitro evaluation of the anti-pancreatic cancer activity of epimedium herb."Frontiers in Pharmacology.2024 Jul;15:
31. [IF=4.9] Zheyuan Shen et al."Rapid evaluation of the quality of Epimedium with different processing degrees by E-eye and NIR spectroscopy combined with machine learning."MICROCHEMICAL JOURNAL.2024 Oct;205:111181
30. [IF=3.8] Ali Nasir et al."In situ growth of dual-responsive polymer as coating for open tubular capillary electrochromatographic separation of epimedins."ANALYTICAL AND BIOANALYTICAL CHEMISTRY.2024 Jun;:1-10
29. [IF=5.4] Yi-min Liu et al."Uncovering the key pharmacodynamic material basis and possible molecular mechanism of extract of Epimedium against liver cancer through a comprehensive investigation."JOURNAL OF ETHNOPHARMACOLOGY.2023 Dec;317:116765
28. [IF=5.572] Zhen Zhao et al."An integrated strategy combining network toxicology and feature-based molecular networking for exploring hepatotoxic constituents and mechanism of Epimedii Folium-induced hepatotoxicity in vitro."FOOD AND CHEMICAL TOXICOLOGY.2023 Jun;176:
27. [IF=6.208] Jiaqi Zhang et al."The Effect of Epimedium Isopentenyl Flavonoids on the Broiler Gut Health Using Microbiomic and Metabolomic Analyses."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2023 Jan;24(8):7646
26. [IF=6.352] Lin Yu et al."Highly efficient bioconversion of icariin to icaritin by whole-cell catalysis."Microbial Cell Factories.2023 Dec;22(1):1-11
25. [IF=6.208] Yu Yao et al."A Novel 3-O-rhamnoside: 2″-O-xylosyltransferase Responsible for Terminal Modification of Prenylflavonol Glycosides in Epimedium pubescens Maxim.."INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES.2022 Jan;23(24):16050
24. [IF=1.698] Jinyan Wu et al."Chemical Identification and Antioxidant Screening of Bufei Yishen Formula using an Offline DPPH Ultrahigh-Performance Liquid Chromatography Q-Extractive Orbitrap MS/MS."International Journal of Analytical Chemistry.2022 Oct 15;2022:142380
23. [IF=5.988] Qihan Luo et al."Chang qing formula ameliorates colitis-associated colorectal cancer via suppressing IL-17/NF-κB/STAT3 pathway in mice as revealed by network pharmacology study."Frontiers in Pharmacology.2022; 13: 893231
22. [IF=4.996] Yuan Jie et al."Systematic characterization of the components and molecular mechanisms of Jinshui Huanxian granules using UPLC-Orbitrap Fusion MS integrated with network pharmacology."Scientific Reports.2022 Jul;12(1):1-24
21. [IF=5.988] Li Pin et al."Epimedium koreanum Nakai–Induced Liver Injury—A Mechanistic Study Using Untargeted Metabolomics."Frontiers in Pharmacology.2022 Jul;0:2288
20. [IF=5.34] Dong Shao et al."Identification of the active compounds and functional mechanisms of Jinshui Huanxian formula in pulmonary fibrosis by integrating serum pharmacochemistry with network pharmacology."PHYTOMEDICINE. 2022 Jul;102:154177
19. [IF=3.361] Yuhao Zhang et al."An integrated approach for structural characterization of Gui Ling Ji by traveling wave ion mobility mass spectrometry and molecular network."Rsc Adv. 2021 Apr;11(26):15546-15556
18. [IF=3.757] Congyan Liu et al."Enhanced hydrolysis and antitumor efficacy of Epimedium flavonoids mediated by immobilized snailase on silica."Process Biochem. 2019 Nov;86:80
17. [IF=4.36] Kun Shi et al."Epimedii Folium and Curculiginis Rhizoma ameliorate lipopolysaccharides-induced cognitive impairment by regulating the TREM2 signaling pathway."J Ethnopharmacol. 2022 Feb;284:114766
16. [IF=4.411] Zhenxian Qin et al."A Widely Metabolomic Analysis Revealed Metabolic Alterations of Epimedium Pubescens Leaves at Different Growth Stages."Molecules. 2020 Jan;25(1):137
15. [IF=4.545] Yan-dan Zhou et al."Icariin ameliorates cisplatin-induced cytotoxicity in human embryonic kidney 293 cells by suppressing ROS-mediated PI3K/Akt pathway."Biomed Pharmacother. 2019 Jan;109:2309
14. 蘭海,劉欣妍,余玲,莫諾蘭,張燕,郭子右,吳清.大孔樹脂純化淫羊藿中朝藿定與淫羊藿苷工藝研究[J].中草藥,2020,51(17):4473-4481.
13. 許婷,黃萌萌,李瑞云,楊茹,劉麗芳,陳彥.多基原淫羊藿不同部位質(zhì)量評價研究[J].中草藥,2020,51(01):190-196.
12. 吳嫣艷,任會旭,馮友龍,張莉,張妤琳.安神補腦膠囊HPLC指紋圖譜與3種成分含量測定方法研究[J].廣東藥科大學(xué)學(xué)報,2020,36(06):778-783.
11. 彭靜, 馬益華, 陳彥,等. 固定化蝸牛酶同時生物轉(zhuǎn)化淫羊藿中4種黃酮苷[J]. 中成藥, 2016, 38(9):1984-1990.
10. 高霞, 陳彥, 王瑩,等. 糊精濕法制粒對淫羊藿總黃酮酶解的影響[J]. 中成藥, 2014, 36(007):1392-1397.
9. 高霞, 劉璇, 陳彥,等. 淫羊藿總黃酮的生物轉(zhuǎn)化過程分析[J]. 中國中藥雜志, 2013, 38(23):4079.
8. 劉聰燕, 高霞, 陳彥,等. 淫羊藿總黃酮在骨質(zhì)疏松大鼠體內(nèi)的藥動學(xué)行為[J]. 中成藥, 2017, 39(008):1595-1600.
7. 劉聰燕, 高霞, 黃萌萌,等. 淫羊藿總黃酮仿生酶解腸溶膠囊的制備及評價[J]. 中草藥, 2016(20).
6. 張燕. 大孔吸附樹脂分離純化淫羊藿EF5黃酮[J]. 北方藥學(xué), 2015, 000(011):11-13.
5. 李婧,王英哲,劉玉翠,景志賢,閆莉,郭俊杰,姜大成,肖井雷.地理環(huán)境因子對朝鮮淫羊藿黃酮類成分空間分布影響的探測分析[J].中國中藥雜志,2019,44(24):5368-5374.
4. 劉聰燕 高霞 陳彥 等. 仿生酶解腸溶膠囊提高淫羊藿總黃酮口服生物利用度的可行性研究[J]. 中國醫(yī)藥工業(yè)雜志 2016(9期):1158-1164.
3. 王英哲 姜大成 容路生 肖井雷 張強 翁麗麗.東北產(chǎn)朝鮮淫羊藿中黃酮類成分的對比分析[J].藥物分析雜志 2019 39(11):2034-2040.
2. 洪雅丹 張凌風(fēng) 潘娉娉 等. HPLC法同時測定淫羊藿-骨碎補藥對中7種成分[J]. 中成藥 2019 041(006):1316-1321.
1. 楊茹 劉聰燕 許婷 等. 5種大孔吸附樹脂對淫羊藿總黃酮的吸附特性考察[J]. 中國實驗方劑學(xué)雜志 2020 v.26(06):121-128.
從2011年開始我們致力于在生命科學(xué)領(lǐng)域、生物醫(yī)學(xué)實驗技術(shù)及論文潤色服務(wù)，協(xié)助客戶各類實驗服務(wù)及論文潤色十多年，是您值得信賴的科研合作伙伴!
如果您受時間、試驗條件等限制而無法完成您的課題研究，歡迎您與我們聯(lián)系。
實驗技術(shù)服務(wù)：
| |||
| |||
| |||
| |||
| |||
|
